Expression of PD-L1, PD-L2, and IDO1 on tumor cells and density of CD8-positive tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma according to histological subtype-Reference-Cited by-同舟云学术

Expression of PD-L1, PD-L2, and IDO1 on tumor cells and density of CD8-positive tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma according to histological subtype

Published:2020-05-14 Issue:10 Volume:146 Page:2639-2650
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Takada Kazuki^ORCID,Toyokawa Gouji,Kinoshita Fumihiko,Jogo Tomoko,Kohashi Kenichi,Wakasu Sho,Ono Yuki,Tanaka Kensuke,Oba Taro,Osoegawa Atsushi,Tagawa Tetsuzo,Azuma Koichi,Okamoto Isamu,Shimokawa Mototsugu,Oda Yoshinao,Mori Masaki

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-020-03250-6.pdf

Reference40 articles.

1. Antonia SJ et al (2017) Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med 377:1919–1929. https://doi.org/10.1056/NEJMoa1709937

2. Antonia SJ et al (2018) Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. N Engl J Med 379:2342–2350. https://doi.org/10.1056/NEJMoa1809697

3. Borghaei H et al (2015) Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med 373:1627–1639. https://doi.org/10.1056/NEJMoa1507643

4. Brahmer J et al (2015) Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med 373:123–135. https://doi.org/10.1056/NEJMoa1504627

5. Erdag G et al (2012) Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Can Res 72:1070–1080. https://doi.org/10.1158/0008-5472.can-11-3218

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic implications, genomic and immune characteristics of lung adenocarcinoma with lepidic growth pattern;Journal of Clinical Pathology;2024-08-03

2. Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation–Cancer Interface;Cancers;2023-05-24

3. Correlation between PD-L1 expression and radiomic features in early-stage lung adenocarcinomas manifesting as ground-glass nodules;Frontiers in Oncology;2022-09-13

4. Characteristics and Prognostic Nomogram for Primary Lung Lepidic Adenocarcinoma;Canadian Respiratory Journal;2022-08-31

5. Endothelial Progenitor Cells as Biomarkers of Cardiovascular Pathologies: A Narrative Review;Cells;2022-05-18